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SUMMARY  
 
Type VII collagen is the main component of anchoring fibrils, structures integral to basement 
membrane homeostasis in skin. Mutations in the gene encoding type VII collagen, COL7A1, 
cause recessive dystrophic epidermolysis bullosa (RDEB) an inherited skin blistering 
condition complicated by frequent aggressive cutaneous squamous cell carcinoma (cSCC). 
OATP1B3, encoded by the gene SLCO1B3, is a member of the OATP (organic anion 
transporting polypeptide) superfamily responsible for transporting a wide range of 
endogenous and xenobiotic compounds. OATP1B3 expression is limited to the liver in 
healthy tissues but is frequently detected in multiple cancer types and is reported to be 
associated with differing clinical outcome. The mechanism and functional significance of 
tumour specific OATP1B3 expression has yet to be determined. Here, we identify SLCO1B3 
(encoding OATP1B3) expression in tumour keratinocytes isolated from RDEB and UV 
induced cSCC and demonstrate that SLCO1B3 expression and promoter activity are 
modulated by type VII collagen. We demonstrate that reduction of SLCO1B3 expression 
upon full length type VII collagen expression in RDEB cSCC coincides with acquisition of 
front to rear polarity and increased organisation of 3D spheroid cultures. In addition we show 
that type VII collagen positively regulates the abundance of markers implicated in cellular 
polarity, namely ELMO2, PAR3, E-cadherin, B-catenin, ITGA6 and Ln332.  
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INTRODUCTION 
Non-melanoma skin cancer (NMSC) incidence is highest among all malignancies in 
Caucasian populations (Toms, 2004; CancerResearchUK, 2012). Approximately 80% of 
NMSC comprise basal cell carcinoma (BCC) and 20% cutaneous squamous cell carcinoma 
(cSCC) (Alam and Ratner, 2001; Yanofsky et al., 2011). BCC is usually a benign disease and 
is rarely responsible for skin cancer related mortality whereas cSCC can develop into 
metastatic disease and contributes to around 1 in 4 skin cancer deaths in the UK (ISD 
Scotland; http://www.isdscotland.org/isd/183.html). The main risk factor for cSCC in the 
general population is UV radiation (Fears and Scotto, 1983; Preston and Stern, 1992) but 
other factors such as HPV infection (McGregor and Proby, 1996; Harwood and Proby, 2002) 
and immunosuppression in organ transplant patients (Rowe et al., 1992; Veness et al., 1999) 
have been documented. Inherited skin disease can also predispose to developing cSCC (Ng et 
al., 2011); in particular, individuals diagnosed with recessive dystrophic epidermolysis 
bullosa (RDEB) (Reed et al., 1975; Fine et al., 2009). Patients with this disease are affected 
by deleterious mutations in COL7A1 leading to either defective or absent type VII collagen 
(Christiano et al., 1993). Type VII collagen is the main component of anchoring fibrils, 
structures which associate with the basement membrane and are essential for the proper 
attachment of the dermis to the epidermis (Sakai et al., 1986; Burgeson, 1993). Type VII 
collagen interacts with proteins localised close to the basement membrane; laminin 332 
(Ln332) and type IV collagen (Chen et al., 1997; Rousselle et al., 1997), as well as banded 
collagen I containing fibrils localised in the dermis (Villone et al., 2008) providing strong 
adhesive connection between these two compartments.  Over 90% of RDEB patients develop 
metastatic cSCC by age 55, a figure significantly higher than the general population where 
metastatic disease is relatively rare (Weinstock et al., 1991; Miller and Weinstock, 1994; Fine 
et al., 2009). The underlying molecular mechanism driving predisposition to develop 
aggressive cSCC in RDEB is not fully understood (South and O'Toole, 2010) although recent 
data from our laboratory shows that tumour microenvironment, in particular the composition 
of extracellular matrix in RDEB is tumour promoting (Ng et al., 2012). Similarly, despite an 
alarming rise in cSCC incidence in the general population and a relatively low 5-year survival 
in patients presenting with regional metastasis (Rowe et al., 1992; Czarnecki et al., 1994), 
little is understood about those tumours with poor prognosis. 
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We previously identified very few differentially expressed genes (DEGs) using microarray to 
compare RDEB with UV induced cSCC in a relatively small number of keratinocyte cultures 
(n=9) (Watt et al., 2011). We further investigate those 18 DEGs and identify SLCO1B3, a 
gene which encodes the liver specific organic anion transporter polypeptide OATP1B3, as 
being up regulated in both UV induced and RDEB cSCC when compared with normal skin. 
Transporter-genes are biologically significant for cell homeostasis and can regulate cellular 
mechanisms such as metabolism, cell death and motility (Olk et al., 2009; Klaassen and 
Aleksunes, 2010). OATP1B3 is normally expressed in the liver and is involved in the 
transport of bile salts, glutathione and other organic anions (Smith et al., 2005a; Hagenbuch 
and Gui, 2008). In agreement with our data, OATP1B3/SLCO1B3 is frequently up-regulated 
in solid tumours including breast and colon (Lockhart et al., 2008; Maeda et al., 2010; 
Pressler et al., 2011) and is has been suggested that OATP1B3 has therapeutic potential 
owing to its ability to transport a broad range of drugs including methotrexate, paclitaxel, 
docetaxel, bromsulphalein (BSP) and pitavastatin (Smith et al., 2005b; Hagenbuch and Gui, 
2008). OATP1B3 expression has been reported to associate with clinical outcome in a 
number of studies (Hamada et al., 2008; Lockhart et al., 2008) yet little data exist on the 
mechanism of expression or functional consequence. Lee and colleagues report that 
OATP1B3 promotes apoptotic resistance in tumour cells (Lee et al., 2009) while very 
recently hypoxia has been shown to positively regulate OATP1B3 expression (Ramachandran 
et al., 2013)  
Here, we investigate the relationship between type VII collagen and tumour expression of 
SLCO1B3 and demonstrate that type VII collagen, Ln332 and ELMO2 regulate tumour 
expression of SLCO1B3. We also go on to show that expression of type VII collagen in 
RDEB cSCC keratinocytes promotes front to rear polarity on uncoated plastic and increases 
organisation of 3D spheroid cultures. These structural changes in response to type VII 
collagen expression coincide with an increase in the abundance of markers implicated in 
cellular polarity, namely ELMO2, PAR3, E-cadherin, B-catenin, ITGA6 and Ln332. 
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RESULTS 
SLCO1B3 is expressed in cSCC in vitro and in vivo 
We previously identified only 18 genes to be significantly differentially expressed between 
cultured RDEB cSCC keratinocytes and UV induced cSCC keratinocytes using gene 
expression arrays demonstrating these two tumour groups are not significantly different in 
this assay (Watt et al., 2011). Initial follow-up of these 18 genes comparing 3 RDEB cSCC 
and 3 UV cSCC cultures using sybr®green qPCR revealed 12 genes showed the same trend 
as array data but only 5 were significantly dysregulated: SLCO1B3, DUSP23, TJAP1, SNRPN 
and SNURF (data not shown). From these five genes, SLCO1B3 showed a consistent up-
regulation in RDEB cSCC keratinocytes in culture compared with normal primary 
keratinocytes and the majority of UV induced cSCC keratinocytes, with the exception of 
SCCT8 (Fig. 1A). However this experiment also identified a significant increase in 
expression in the majority of UV induced cSCC keratinocytes when compared with normal 
keratinocytes. Six of eight cultured cSCC cell lines showed a greater level of expression 
compared with the hepatocellular carcinoma cell line HepG2 (Fig. 1A). 
Q-PCR using reverse transcribed mRNA obtained from patient tissues showed high 
SLCO1B3 expression in RDEB cSCC, and to a lesser extent UV induced cSCC and RDEB 
non-SCC skin compared with normal skin, with the highest levels evident in RDEB cSCC 
tissue (Fig. 1B).  
 
Endogenous OATP1B3 expression is detectable in cSCC keratinocytes but only localises 
to the membrane in vivo 
OATP1B3 expression was readily detected in cSCC keratinocytes but not in normal primary 
keratinocytes in culture (Fig. 2A). Plasma membrane bound OATP1B3 was however not 
observed in cultured cSCC keratinocytes using indirect immunofluorescence unless over-
expressed via retroviral transduction (Fig. 2B). Membrane bound protein was detected in 
organotypic 3D cultures (data not shown) and xenograft tumours (Fig. 2B right panels). 
Tissue sections obtained from RDEB cSCC (n=7), RDEB skin (n=3) and UV induced cSCC 
(n=6) patients along with normal human liver (positive control) and normal human skin 
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(negative control) were assessed for OATP1B3 expression.  6/7 RDEB cSCC and 5/6 cSCC 
samples showed heterogeneous plasma membrane bound protein expression along with 
nuclear localisation in 3/7 RDEB cSCC and 2/6 cSCC tissues (Fig. 3A upper panels and Fig. 
3B). 1/3 RDEB skin samples showed membrane bound protein (Fig. 3A lower panels). Co-
localisation with plakoglobin confirmed membrane localisation although higher levels of 
OATP1B3 were readily detected in regions of cSCC tissue where membrane bound 
plakoglobin was absent (Fig. 3B).  
 
SLCO1B3 expression is regulated by type VII collagen 
We noted that when wild-type COL7A1 was expressed in RDEB cSCC keratinocytes 
(SCCRDEB-C7 cells) the level of SLCO1B3 expression was reduced compared with empty 
vector control cells (SCCRDEB-EV cells) (p=0.004, Fig. 4A). This observation was 
confirmed using separate clonal populations of transduced cells ruling out any insertion 
effects (Fig. 4A-C). To determine whether type VII collagen had a direct effect on promoter 
activity of SLCO1B3 we cloned the SLCO1B3 promoter, previously described in Jung et al., 
2002 (Jung et al., 2002) and transfected a SLCO1B3 promoter-driven luciferase construct into 
either SCCRDEB3-C7 or SCCRDEB3-EV cells. SLCO1B3 promoter activity was 
significantly (p=0.02) reduced in collagen VII transduced SCCRDEB3 keratinocytes 
compared to control cells (Fig. 4D).  
Further, SLCO1B3 expression was significantly reduced in two separate patient derived 
parental populations of RDEB SCC cells, SCCRDEB3 and SCCRDEB2, when cultured on 
matrix derived from SCCRDEB3-C7 cells compared to matrix derived from SCCRDEB3-EV 
vector control cells (Fig. 4E).  
We then used siRNA mediated depletion of COL7A1 to show that reduction of recombinant 
type VII collagen increases SLCO1B3 expression in a clonal population of SCCRDEB3-C7 
cells (Fig. 5A-B). We note that in this experiment the NT control level of SLCO1B3 was 
greater in SCCRDEB3-EV cells than SCCRDEB3-C7 cells as expected (1.5 fold) yet the 
impact of siRNA mediated depletion of COL7A1 resulted in a greater increase in SLCO1B3 
levels than seen in the EV population (Fig. 5B). We attribute this observation to the clonal 
nature of the two cell populations. To confirm the observation that siRNA depletion of 
COL7A1 increased SLCO1B3 expression in non-clonal populations we next used siRNA 
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depletion of COL7A1 in SCCRDEB4-C7 cells (Fig. 5C) and the UV induced, nonRDEB 
cSCC keratinocyte population, SCCT8 (Fig. 5D) providing a direct link to type VII collagen 
and SLCO1B3 tumour keratinocyte expression. The same effect was also observed in normal 
primary keratinocytes (NHK) following type VII collagen knock down, although the overall 
level of expression was significantly lower than in tumour cells (supplementary Fig. 1).  
 
Expression of the polarity related protein ELMO2 is regulated by type VII collagen 
OATP1B3 is a transmembrane transporter and is expressed in the basolateral component of 
the plasma membrane. Type VII collagen is a basement membrane protein that directly binds 
to Ln332 which itself binds with integrin receptors. It has been previously reported that 
expression of cell surface proteins can be regulated by interactions with basement membrane 
components that influence cellular polarity (Li et al., 2003; Daley et al., 2012). We therefore 
postulated that although OATP1B3 was not observed to be asymmetrically localised in 
tumour keratinocytes adjacent to extracellular matrix (Fig.3) absence of type VII collagen 
might regulate its expression by altering cellular polarity.  
Other than basement membrane associated proteins in basal keratinocytes or tight junction 
components in upper stratified keratinocytes, asymmetrically distributed apical basal polarity 
markers have yet to be defined in the epidermis (Niessen et al., 2012). Better described is the 
redistribution of proteins involved in the assembly and disassembly of focal adhesions during 
the acquisition of front to rear polarity in cultured single cells (Hamill et al., 2009; Ho and 
Dagnino, 2012b). Front to rear polarity in cultured primary murine keratinocytes in response 
to Ln332 is mediated in part by a focal adhesion complex containing the relatively novel 
protein engulfment and motility 2, or ELMO2 (Ho et al., 2009; Ho and Dagnino, 2012b). We 
therefore investigated whether a relationship existed between ELMO2, type VII collagen and 
OATP1B3.  
Overexpression of type VII collagen resulted in up regulation of ELMO2 expression in 
SCCRDEB3-C7 cells (Fig. 6A). Concurrently, siRNA mediated depletion of COL7A1 in four 
independent tumor cell populations resulted in a reduction in ELMO2 expression; 
SCCRDEB3-C7 and SCCRDEB4-C7 cells as well as cSCC cells that endogenously express 
type VII collagen; SCCT8 and SCCT1 (Fig. 6B). ELMO2 protein levels corresponded with 
reduction in transcript (Fig. 6C-D). Further, ELMO2 expression increased in both 
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SCCRDEB3 and SCCRDEB2 keratinocytes that were cultured on matrix derived from 
SCCRDEB3-C7 cells (Fig. 6E-F). These data demonstrate that type VII collagen positively 
regulates ELMO2 expression in cSCC keratinocytes. 
We next investigated the link between ELMO2 and SLCO1B3 expression and showed that 
overexpression of ELMO2 resulted in a reduction in SLCO1B3 mRNA levels in SCCT8 and 
SCCRDEB2 (Fig. 7A-B), whereas a reduction in ELMO2 mRNA resulted in an increase in 
SLCO1B3 expression in SCCT8 (Fig. 7C-D) and non-SCC RDEB keratinocytes 
(supplementary Fig. 2A-C), with a significant increase in SLCO1B3 observed in  normal 
primary keratinocytes after ELMO2 reduction (supplementary Fig. 2D-F).  Thereby, 
demonstrating that like COL7A1, ELMO2 can also negatively regulates SLCO1B3. 
Type VII collagen can regulate SLCO1B3 independent of ELMO2 
To confirm whether expression of SLCO1B3 in cSCC was dependent on expression of either 
type VII collagen or ELMO2 alone, we investigated SLCO1B3 expression following ELMO2 
knock down in type VII collagen overexpressing RDEB cSCC cells (RDEBSCC3-C7) and 
control cells (RDEBSCC3-EV). SLCO1B3 expression significantly increased in RDEBSCC3-
EV cells following ELMO2 knockdown demonstrating ELMO2 can regulate SLCO1B3 in the 
absence of type VII collagen (supplementary Fig. 3A-B). In RDEBSCC3-C7 cells no 
significant difference in SLCO1B3 expression was observed following ELMO2 knock down 
(supplementary Fig. 3A-B), showing that ELMO2 depletion had no effect on SLCO1B3 
expression. In addition we show that ELMO2 does not regulate type VII collagen, as 
observed in SCCT8 (supplementary Fig. 3C-E) or normal primary keratinocytes 
(supplementary Fig. 2A-C) following ELMO2 knock down. We also investigated Ln332, a 
binding partner of type VII collagen and also known to regulate polarity in epithelial cells 
(Kligys et al., 2007). In RDEB cSCC keratinocytes Ln332 siRNA mediated knock down 
resulted in an increase in SLCO1B3 message levels (Fig. 7E-F). This effect was independent 
of ELMO2 expression (supplementary Fig. 3F). Collectively these data show that SLCO1B3 
is regulated independently by proteins with known roles in epidermal polarity (ELMO2 and 
Ln332) and that SLCO1B3 expression is controlled through a single mechanism governed by 
either of these proteins or type VII collagen alone.  
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Type VII collagen regulates front to rear keratinocyte polarity in 2D culture and 
regulates structural organisation in 3D spheroid culture 
Ln332 and ELMO2 have previously been shown to play a role in epidermal polarity (Li et al., 
2003; Ho and Dagnino, 2012b). To investigate whether type VII collagen and could also 
regulate keratinocyte front to rear polarity we seeded RDEBSCC C7 cells at low density and 
assessed lamellipodia formation at 5 hours as described (Hamill et al., 2009) (Fig. 8A). Type 
VII collagen expression marginally increased the number of attached cells that spread onto 
uncoated plastic (Fig. 8B) but strikingly increased the number of lamellipodia observed (Fig. 
8C). Cells displaying front to rear polarity were frequently observed in RDEBSCC C7 cells 
but were completely absent in vector control cells after 5 hours (Fig. 8A).  
The same experiment was repeated in RDEBSCC3 cells following ELMO2 transient 
overexpression to confirm the role of ELMO2 in RDEB cSCC polarity. ELMO2 
overexpressing cells (ELMO2) showed a significant increase in the number of polarised cells 
compared to control cells (EV) (supplementary Fig. 4). 
To investigate whether type VII collagen can influence structural organisation, 3D spheroid 
cultures were established with SCCRDEB3-C7 cells and compared with the empty vector 
controls, SCCRDEB3-EV. SCCRDEB3-C7 spheroids showed increased structural 
organisation determined by morphology (Fig. 8D) and overall increased levels of proteins 
previously associated with cellular polarity, namely PAR3, ELMO2, integrin alpha 6 and 
Ln332 when compared with SCCRDEB3-EV spheroids (Fig. 8D-E). Next we assessed the 
effect of stromal derived type VII collagen on RDEB SCC cells. To do this we co-cultured 
parental SCCRDEB3 cells with fibroblasts either expressing recombinant type VII collagen 
or vector control in a spheroid assay over 7 days. After this time we observed that 
mesenchyme delivery of type VII collagen had a more profound effect on RDEBSCC 
keratinocytes in spheroid culture than RDEBSCC keratinocytes cultured alone in the 
presence or absence of type VII collagen. Spheroid cultures of RDEBSCC cells with 
fibroblast delivered type VII collagen exhibited more distinct separation of cellular 
populations and a clear increase in distribution to the membrane of beta-catenin and e-
cadherin (Fig. 8F). Western blot analyses showed no overall changes in e-cadherin and beta-
catenin protein levels (Fig. 8G) suggesting that the differences observed in solvent fixed 
embedded spheroids (Fig. 8F) are a result of membrane localisation. 
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DISCUSSION 
cSCC is the most common cause of NMSC mortality and represents a significant clinical 
complication in high risk groups, particularly patients with RDEB. UV exposure resulting in 
DNA damage is a well-established driver of cSCC (Armstrong and Kricker, 2001). On the 
contrary, RDEB associated cSCC disease aggression is regarded as UV independent and 
although tumour initiation is still not fully understood (Fine et al., 2009) recent work from 
our laboratory demonstrates the role of microenvironment in RDEB tumour progression (Ng 
et al., 2012). Here our study began by interrogating a small number of changes identified 
through expression array analysis comparing UV with RDEB cSCC keratinocytes in culture. 
In agreement with multiple previous studies little differences were confirmed between these 
two tumour types (Arbiser et al., 2004; Mallipeddi et al., 2004). In fact our primary target, 
SLCO1B3 is aberrantly expressed in a panel of cSCC from both UV induced and RDEB 
induced cSCC cell lines and tissue (Fig. 1), again in agreement with previous studies 
identifying SLCO1B3 expression in cancer (Maeda et al., 2010; Pressler et al., 2011; Svoboda 
et al., 2011). However, by pursuing the molecule responsible for RDEB we show that type 
VII collagen regulates the expression of SLCO1B3 in both RDEB cSCC and UV induced 
cSCC (Fig. 3). Further to this we demonstrate that front to rear polarity and organisation of 
3D spheroid culture coincides with changes in expression of SLCO1B3 in cSCC keratinocytes 
when type VII collagen levels are altered (Fig. 8). 
Polarity is essential for the maintenance of tissue homeostasis and can either be defined as the 
distribution of apical and basal membrane domains within the cell or the positioning of a cell 
within the tissue itself, referred to as planar cell polarity (PCP). Directional transport, 
asymmetric stem cell division, oriented cell division and sensing signals from neighbouring 
microenvironment are a few examples of cellular processes that require the maintenance of 
cell and tissue polarity (Lechler and Fuchs, 2005; Martin-Belmonte and Mostov, 2008; 
Poulson and Lechler, 2010; Martin-Belmonte and Perez-Moreno, 2012). Previously, three 
main protein complexes have been implicated in maintenance of polarity in simple epithelia, 
Par6-Par3-aPKC (Munro, 2006; Goldstein and Macara, 2007), Crumbs-Stardust-PATJ 
complex and Scribble-Lethal giant larvae (Lgl)-Discs large (Dlg) complex (Martin-Belmonte 
and Mostov, 2008; Martin-Belmonte et al., 2008). However, the role of these protein 
complexes in maintenance of stratified epithelia polarity is not clear (Muroyama and Lechler, 
2012; Niessen et al., 2012) and recent work has shown that the engulfment and cell motility 
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protein, ELMO2, positively regulates front to rear keratinocyte polarity by forming 
complexes with ILK in the presence of EGF (Ho et al., 2009; Ho and Dagnino, 2012a; Ho 
and Dagnino, 2012b). The data presented here identify for the first time a link between 
ELMO2 and type VII collagen demonstrating that, like ELMO2, type VII collagen can 
regulate front to rear polarity (Fig. 8A). We go on to demonstrate that like type VII collagen, 
ELMO2 negatively regulates SLCO1B3 (Fig. 7 and supplementary Fig. 2) and this effect is 
independent of the regulation of ELMO2 by type VII collagen (supplementary Fig. 3). We 
also show that Ln332 regulates SLCO1B3 independently of ELMO2 (Fig. 7E-F). Together 
these data suggests that SLCO1B3 expression is not modulated by a common mechanism 
underlying an interaction between type VII collagen and ELMO2 but instead suggests that 
SLCO1B3 expression is modulated by cellular polarity. 
Type VII collagen and Ln332 are secreted proteins important for epidermal keratinocyte 
attachment (Ogawa et al., 2007). Type VII collagen binds Ln332, a key component of 
hemidesmosomes and focal adhesions (Chen et al., 1999). Numerous components of these 
adhesion complexes have been implicated in regulating epithelial polarity (Cox et al., 2001; 
Martin-Belmonte and Perez-Moreno, 2012) and indeed ELMO2 is shown to regulate front-to-
rear polarity in the presence of Ln332 (Ho et al., 2009; Ho and Dagnino, 2012a). Similarly, 
integrin α6β4 regulates keratinocyte attachment via Ln332 and has a well-established role in 
directional migration (Jones et al., 1991; Dowling et al., 1996) since integrin activation of 
focal adhesion kinases is required for leading edge formation and directional movement (Lim 
et al., 2010). Integrin α6β4 also interacts with BPAG1e, promoting keratinocyte polarity 
through modulation of RAC1 (Hamill et al., 2009). We have shown that in the absence of 
type VII collagen ITGA6 and Ln332 expression is significantly reduced in 3D spheroid 
cultures (Fig. 8), suggesting a common mechanism, although further work is necessary to 
confirm this. 
E-cadherin and beta-catenin have described roles in numerous polarity pathways; APC (den 
Elzen et al., 2009), SCRIB (Navarro et al., 2005), PAR3 (Le Borgne et al., 2002), and Hippo 
(Kim et al., 2011); all of which are characterised by a down-regulation in cancer progression 
(Muroyama and Lechler, 2012; Niessen et al., 2012). Our data showing type VII collagen 
regulates the expression of membrane bound e-cadherin in 3D spheroid culture is in 
agreement with a previous study of siRNA depletion of COL7A1 cSCC showing reduced e-
cadherin in 3D organotypic culture (Martins et al., 2009).  Further work will be necessary to 
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determine the precise role that individual complexes play in type VII collagen mediated 
polarity and organisation. Toward this end we show here a reduction of PAR3 in RDEB 
cSCC spheroid culture and it is interesting to note that altered PAR3 distribution has been 
observed as a result of reduced e-cadherin expression (Le Borgne et al., 2002) and that 
deletion of PAR3 in murine epidermis does not alter normal skin development or function but 
does favour keratoacanthoma formation. Consequently, PAR3 wildtype mice show increased 
SCC formation on a background of RAS mutations, suggesting a dual role of PAR3 in skin 
carcinogenesis (Iden et al., 2012). 
Reorganisation of polarity can have a profound effect on proteins located at the cell surface. 
OATP1B3 is a transmembrane transporter that localises in the basolateral domain of the 
plasma membrane in normal liver and the data presented here strongly support a change in 
polarity as an explanation for SLCO1B3 expression on the background of altered tumour cell 
behaviour.  In addition to the identification that type VII collagen regulates OATP1B3 
expression we confirm loss of plasma membrane bound OATP1B3 expression in 2D cultured 
cells, a phenomenon also documented in primary hepatocytes (Ulvestad et al., 2011). Two 
recent studies have identified an N-terminal truncated isoform of OATP1B3, OATP1B3 V1, 
(lacking the first 28 amino acids) as being the predominant OATP1B3 expressed in colon, 
lung and pancreatic cancer (Nagai et al., 2012; Thakkar et al., 2013). Thakkar and colleagues 
demonstrate that OATP1B3 V1 localises predominantly to the cytoplasm in culture (Thakkar 
et al., 2013). Our data show that membrane localised OATP1B3 is absent in cultured SCCT8 
cells but readily detected when these cells are grown in vivo (Fig. 2C). Therefore a more 
detailed analysis of OATP1B3 isoforms expressed in cSCC under these varied conditions is 
warranted. Since it has been suggested that OATP substrates and inhibitors can be used either 
to enable uptake of xenobiotics for the specific targeting of cancer cells or by inhibiting 
OATP mediated transport of hormones to prevent resistance to existing therapies (Maeda et 
al., 2010; Svoboda et al., 2011; Obaidat et al., 2012) it will be of interest to understand the 
relationship between transport and isoform expression. 
In summary we show that tumour expression of SLCO1B3 in cSCC can be regulated by type 
VII collagen and ELMO2 and that expression of type VII collagen in RDEB SCC 
keratinocytes increases front to rear polarity and structural organisation in spheroid culture 
coinciding with dramatic reorganisation of β-catenin and e-cadherin protein localisation. 
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MATERIALS AND METHODS 
 
All human samples were collected after informed, written consent and in accordance with 
Helsinki guidelines. All animals were used in accordance with UK Home Office regulations. 
 
Keratinocyte culture and xenograft tumour material 
Keratinocyte isolation, organotypic culture and xenograft tumour growth were achieved as 
previously described (Nystrom et al., 2005; Watt et al., 2011) 
 
Sybr®Green qPCR validation 
cDNA was prepared from RNA isolated using RNA-Bee (AMS Biotechnology, Abingdon-
on-Thames, UK) and the QuantiTect reverse transcription kit (Qiagen, Manchester, UK). The 
2X Sybr®Green master mix (Qiagen, Manchester, UK) along with the SLCO1B3 forward 
(5’-GTCCAGTCATTGGCTTTGCA-3’) and reverse (5’-
CAACCCAACGAGAGTCCTTAGG-3’) primers, ELMO2 forward (5’- 
GGGACATGGTTTCAATCACC-3′) and reverse (5ʹ-TGGAGGTGTGAGATGAGCTG-
3ʹ) and previously published COL7A1 primers (Wang et al., 2006) were used to quantify 
mRNA levels. GAPDH primers (Forward 5ʹ-TTCCGGGAAACTGTGGCGTGA-3ʹ and 
reverse 5ʹ-ACGGAAGGCCATGCCAG-3ʹ) and previously published ACTB primers 
(Ehrenfeld et al., 2011) were used to normalise expression data. Raw data was analysed with 
the Rotor-Gene Q qPCR software (Qiagen Manchester, UK) using the ∆∆CT method. 
 
Retroviral transduction 
The open reading frame of SLCO1B3 and COL7A1 were cloned from an IMAGE cDNA 
clone (Open Biosystems, Thermo Scientific, Huntsville, AL) or normal keratinocyte cDNA 
respectively and inserted into the pBabe-puro vector using standard molecular biology 
techniques. RDEB cSCC keratinocytes were retrovirally transduced using the Phoenix 
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retroviral packaging system (Kinsella and Nolan, 1996). All transduced cells were selected 
using 2 µg/ml puromycin. SCCRDEB3 cells were then clonally selected to generate a 
homogenous population expressing a high level of type VII collagen. SCCRDEB4 were also 
transduced as described but without clonal selection. 
 
Immunoblotting and Immunofluorescence  
Protein lysates from 2 days post confluent cells were extracted using the 
radioimmunoprecipitation assay (RIPA) buffer and quantified using the bicinchoninic acid 
(BCA) assay (ThermoFisher Scientific, Waltham, USA ). 4-15% Mini-PROTEAN TGX gels 
(Bio-Rad, Hertfordshire, UK) were used for electrophoresis.  
Formalin fixed paraffin embedded (FFPE), fresh frozen tissue sections and cSCC primary 
keratinocytes were used. Briefly, FFPE sections were rehydrated using 100%, 95% and 70% 
ethanol and then treated with 1% citric acid buffer (pH 6) at 100°C. FFPE/fresh frozen 
sections/ keratinocytes cultured on coverslips were stained with the primary antibody for 1 
hour followed by a 40 minute treatment with the secondary antibody and counterstained with 
DAPI (Invitrogen, Paisley, UK).  Slides were imaged using the Zeiss Axioskop 2 fluorescent 
microscope (Carl Zeiss Microscopy, LLC, United States) and analysed using the Axiovision 
software or the Leica TCS SP5 confocal microscope and the Leica Application Suite 
Advanced fluorescence Lite software (Leica Microsystems, Wetzlar, Germany). 
 
Antibodies 
The following antibodies were used for immunofluorescence and westernblot analysis. 
Primary antibodies used: OATP1B3: H-52 (0.4 µg/ml, Santa Cruz, biotechnology, Dallas, 
Texas, USA), type VII collagen: 234192, (Calbiochem, Darmstadt, Germany), ELMO2: 
either the E-16 clone (0.8 µg/ml, Santa Cruz, biotechnology, Dallas, Texas, USA) or 
HPA018811 (0.4 µg/ml, Sigma- Aldrich, Dorset, UK), Integrin alpha 6: 3750 (Cell 
Signalling, Danvers, USA), e-cadherin: (2.5 µg/ml, 610101, BD Transduction 
Laboratories™, San Jose, CA, USA),  Laminin 332: γ chain MAB19562, (1 µg/ml, 
Calbiochem, Darmstadt, Germany), β-catenin: SC-7199 (4 µg/ml, Santa Cruz, biotechnology, 
Dallas, Texas, USA), PAR3: 07-330 (0.4 µg/ml, Calbiochem, Darmstadt, Germany), Actin: 
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SC-58625 (0.2 µg/ml, Santa Cruz, biotechnology, Dallas, Texas, USA) and Plakogloblin: 
61005, (2.5 µg/ml, Progen Biotechnik, Heidelburg, Germany). Secondary antibodies used: 
Alexafluor 594® rabbit (2.5 µg/ml, Invitrogen, Paisley, UK) or Alexafluor 488® mouse (2.5 
µg/ml, Invitrogen, Paisley, UK) 
 
Luciferase gene reporter assay 
A luciferase gene reporter construct was created by inserting the SLCO1B3 promoter (1Kb 
upstream of the 5’UTR region of the gene: 11375105 - 11376214 of accession number: 
NW_001838052.1) (Jung et al., 2002) into the pGL3 basic vector using standard molecular 
biology techniques. SCCRDEB3 cells transduced with COL7A1 ORF or empty vector control 
were transfected with the SLCO1B3 promoter construct using Lipofectamine 2000 
(Invitrogen, Paisley, UK) according to the manufacturer’s recommendations.  Cells were 
lysed and harvested after 18 hours and luciferase activity was recorded using the Dual-
Luciferase® reporter assay system (Promega, Madison, USA) and a Modulus II plate reader 
(Promega, Madison, USA). Data was normalised for transfection efficiency using renilla and 
empty vector control cells were used as a calibrator. 
 
SiRNA knock down of COL7A1, LAMC2 and ELMO2 
Three siRNA constructs against COL7A1 (SASI_Hs01_00155170/71/73, Sigma-Aldrich, 
Dorset, UK), LAMC2 (SASI_Hs01_00136952/53/54, Sigma-Aldrich, Dorset, UK), ELMO2 
(SASI_Hs01_00078453/54/55, Sigma-Aldrich, Dorset, UK) and a custom designed non-
targeting control (sense: GCUGCUAGACGUGUUAUGA[dT][dT], antisense: 
UCAUAACACGUCUAGCAGC[dT][dT], Sigma-Aldrich, Dorset, UK ) were transfected 
using Lipofectamine 2000 (Invitrogen, Paisley, UK). RNA was extracted 24, 48 and 72 hours 
post transfection and analysed for COL7A1, SLCO1B3, LAMC2 and ELMO2 expression 
using Sybr®Green qPCR.  
 
ELMO2 overexpression 
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An ELMO2 cDNA construct (MHS1010-57517, Thermo Scientific, Waltham, USA) and the 
empty vector control was transfected into cSCC keratinocytes using Lipofectamine 2000 
(Invitrogen, Paisley, UK). RNA and protein was harvested 17 hours and 24 hours post 
transfection and assessed for ELMO2 overexpression using Sybr®Green qPCR. 
 
Cell derived matrix  
SCCRDEB3-C7 and SCCRDEB3-EV cells were cultured in a 6 well plate until 2 days post 
confluent. Cells were washed with cold PBS and lysed with 1ml 0.5% sodium deoxycholate 
for 10 minutes on ice. Lysed cells were removed and wells were washed with dH2O and air 
dried. SCCRDEB2 and SCCRDEB3 parental cells were seeded on either collagen VII 
containing matrix or empty vector control matrix for 3 days before RNA and protein samples 
were harvested. 
 
Cell plating lamellipodia scoring 
500,000 SCCRDEB3-C7 and SCCRDEB-EV cells were seeded in a 10 cm dish. Cells were 
imaged 5 hrs post seeding. Twenty frames were scored blind for each cell type and data was 
analysed from three independent experiments. Clear cellular protrusions were counted for 
lamellipodia scoring and difference in cell diameter was observed in order to accurately score 
for cell spreading. Leica TCS SP5 confocal microscope was used to image cells after staining 
with β-actin and analysed using the Leica Application Suite Advanced fluorescence Lite 
software (Leica Microsystems, Wetzlar, Germany). 
 
Spheroid mono-culture  
SCCRDEB3 type VII collagen overexpressing (SCCRDEB3-C7) and the empty vector cells 
(SCCRDEB3-EV) cells were cultured for 72 hours in a hanging drop non-adherent culture. 
Briefly, 6000 cells were seeded on the lid of a 10 cm culture dish and allowed to form 
spheroids. Each spheroid was washed with PBS and harvested using a syringe and placed in 
4% paraformaldehyde overnight. Spheroids were washed with PBS next day and placed at 
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4°C and embedded in paraffin. Alternatively, spheroids were washed with PBS and directly 
frozen in OCT. Spheroids were serially sectioned for immunofluorescence. 
 
Spheroid co-culture  
Fibroblasts were transduced with COL7A1 or empty vector controls. 3,000 fibroblasts were 
seeded in 20 µL media on a sterile 10 cm cell culture dish lid and incubated for four days at 
37°C. On day four, 10 µL of culture media was removed from each droplet.  6,000 
keratinocytes were seeded in 10 µL of media onto each droplet of previously formed 
fibroblasts spheroids and cultured for three days. Spheroids were washed with PBS and 
embedded in OCT for serial sectioning and staining. In parallel and to visualise the separate 
populations, cells were labelled with PKH67 green fluorescent cell linker kit (fibroblasts) or 
PKH26 red fluorescent cell linker kit (keratinocytes) according to the manufacturer’s 
protocol (Sigma-Aldrich, St Louis, USA). Labelled spheroids were visualised using the Carl 
Zeiss Axiovert25 CFL microscope (Carl Zeiss Microscopy, LLC, United States). 
 
Statistical analysis 
Student’s two tailed T-test was used to determine statistical significance of luciferase gene 
reporter assays and COL7A1 siRNA knockdown data. 
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FIGURE LEGENDS 
Figure 1: SLCO1B3 is up-regulated in cSCC derived keratinocytes and primary tissue.  
A.SLCO1B3 mRNA expression as assessed by Sybr®Green qPCR in 6 cSCC, 3 RDEB 
cSCC, 2 metastatic cSCC, 1 normal human keratinocyte (NHK) and 1 hepatocellular 
carcinoma (HepG2) culture. The expression levels were calculated using the ∆∆CT method 
with ACTB as the normaliser and NHK as the calibrator. B. Sybr®Green qPCR analysis of 
SLCO1B3 mRNA levels in tissue from 11 RDEB cSCC, 3 RDEB skin, 3 cSCC, 1 normal 
skin (NHS) and 1 normal liver. The expression levels were calculated using the ∆∆CT 
method with ACTB as the normaliser and NHS as the calibrator. Experiment repeated twice, 
data from the same experiment, performed in triplicate, is shown as the mean ± s.d. 
 
Figure 2: OATP1B3 is endogenously expressed in cSCC derived keratinocytes 
A. Endogenous OATP1B3 protein expression was detected using immunoblotting in cSCC 
keratinocytes, but not in normal human keratinocytes (NHK). SLCO1B3 overexpressing cells 
(OATP1B3_SCCRDEB2) were used as a positive control. EV_SCCRDEB2 = empty vector 
control cells. Adjacent western blot quantification graph shows percentage average relative 
OATP1B3 protein density (n=3, mean ± s.d). B. OATP1B3 protein expression is readily 
detected in monolayer 2D cultured cells (SCCT8) (left panels) but is only localised to the 
plasma membrane when it is over-expressed in 2D culture (middle panels) or in mouse 
xenograft tumours (right panels) using the same SCCT8 cells. Top panel shows 
immunostaining with an antibody raised against OATP1B3 while bottom panel shows DAPI 
nuclear staining, Bar = 10 µm. 
 
Figure 3: OATP1B3 is overexpressed in cSCC, RDEB cSCC and RDEB patient skin but 
is absent from normal skin. 
A. cSCC tissues and RDEB patient skin analysed for OATP1B3 showed a strong plasma 
membrane protein expression along with nuclear localisation. Normal liver was used as a 
positive control and normal skin as a negative control for immunofluorescence. Top panel 
shows OATP1B3 immunostaining and the lower panel shows DAPI counter stain for all 
tissues. Bar = 10 µm. B. Confocal images of cSCC tissue showing OATP1B3 in red and 
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plakogloblin in green. The merge image shows OATP1B3 nuclear staining (indicated by 
yellow arrows) and plasma membrane co-localisation with plakogloblin (indicated by white 
arrows). Bar = 10 µm. 
 
Figure 4: SLCO1B3 expression is negatively regulated by full length type VII collagen in 
both RDEB cSCC and UV induced cSCC keratinocytes.  
A. SCCRDEB3 keratinocytes transduced with full length COL7A1 (clones C7-6 and C7-9) 
show reduced SLCO1B3 mRNA levels compared to the empty vector cells (EV) as 
determined by Sybr®Green qPCR analysis. The expression levels were calculated using the 
∆∆CT method with ACTB as the normaliser and EV as the calibrator. B. Western blot 
confirms type VII collagen overexpression and reduced OATP1B3 expression in both 
SCCRDEB3 C7-6 and C7-9 clones compared to the empty vector control. C. Western blot 
quantification shows relative average OATP1B3 protein density from B (n=3, mean ± s.d). D.  
A dual luciferase gene reporter assay was designed to assess the effect of COL7A1 on 
SLCO1B3 promoter activity, which was significantly reduced in the type VII collagen 
overexpressing cells (C7-6), compared to the empty vector (EV) controls. E. SLCO1B3 
expression is significantly reduced when SCCRDEB3 and SCCRDEB2 cells are cultured on 
matrix derived from type VII collagen overexpressing cells (C7-6) compared to the empty 
vector control (EV). Experiments performed in triplicate and data is shown as the means ± 
s.d. **p<0.005 and *p<0.05. 
 
Figure 5: SLCO1B3 mRNA expression is increased following COL7A1 knock down in 
both UV induced and RDEB cSCC keratinocytes. 
 A. Type VII collagen knock down was achieved using three siRNA constructs in clonal 
populations of SCCRDEB3 C7 and EV cells (SiC7-1, SiC7-2 and SiC7-3) and compared to 
the non-targeting control (NT). B. SLCO1B3 mRNA levels showed a significant increase in 
type VII collagen overexpressing cells following COL7A1 knock down compared to the 
empty vector control cells. The same assay was repeated for C. SCCRDEB4-C7 and D. 
SCCT8 cells.  
 
Figure 6: Type VII collagen positively regulates ELMO2 expression in cSCC 
keratinocytes. 
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A. Type VII collagen re-expression in SCCRDEB3 keratinocytes (C7-6) results in an 
increase in ELMO2 expression. The expression levels were calculated using the ∆∆CT 
method with GAPDH as the normaliser and empty vector control (EV) as the calibrator. B. 
Type VII collagen knock down was achieved using a siRNA pool (SiC7 pool) and compared 
to non-targeting control (NT). ELMO2 mRNA levels showed a significant decrease in both 
UV induced cSCC and type VII collagen overexpressing RDEB cSCC keratinocytes 
following COL7A1 knock down compared to the empty vector control cells. C. Western blot 
confirms an increase in ELMO2 expression in SCCRDEB3 keratinocytes following COL7A1 
expression and a reduction in ELMO2 expression in UV induced cSCC keratinocytes 
(SCCT1) following COL7A1 knock down. Adjacent western blot quantification graphs show 
percentage average relative ELMO2 protein density (n=3, mean ± s.d).  D. 
Immunofluorescence images confirm the loss of ELMO2 expression following type VII 
collagen knock down in SCCT8. Bar = 10 µm E. ELMO2 expression was significantly 
increased when SCCRDEB3 and SCCRDEB2 cells were cultured on matrix derived from 
type VII collagen overexpressing cells (C7-6) compared to the empty vector control (EV). F. 
Immunofluorescence images confirming an increase in ELMO2 expression when 
SCCRDEB3 cells were cultured on matrix derived from C7-6 cells compared to EV. Bar = 10 
µm. Experiments performed in triplicate and the data is shown as the means ± s.d. **p<0.005 
and *p<0.05. 
 
Figure 7: ELMO2 and Ln332 regulate SLCO1B3 expression in cSCC keratinocytes 
A. ELMO2 was transiently overexpressed in SCCT8 and SCCRDEB2 cells. Inset western 
blot confirms ELMO2 overexpression in SCCRDEB2 cells. ELMO2 = overexpressing cells 
and EV = empty vector control B.  SLCO1B3 expression was reduced in both SCCT8 and 
SCCRDEB2 keratinocytes following ELMO2 overexpression, C. ELMO2 knock down was 
achieved in SCCT8 using a pool of three siRNA constructs (SiEL2 pool). D. SLCO1B3 
mRNA levels were increased following ELMO2 depletion compared to the non-targeting 
control (NT). E. Western blot showing a reduction of the gamma 2 chain of Ln332 
expression in SCCRDEB3 cells following knock down using a pool of three siRNA 
constructs after 48 and 72 hours.  SLCO1B3 expression was increased in Ln332 knock down 
cells (SiLn332-48 hr/72 hr) compared to the non-targeting control (NT). Experiment 
performed in triplicate and represented as the means ± s.d. *p<0.05. 
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Figure 8: Type VII collagen overexpression imparts front-to-rear polarity and increased 
expression of polarity associated proteins in cSCC. 
A. Confocal images of individual cells labelled with actin (green) showing retrovirally 
transduced type VII collagen overexpressing keratinocytes (C7-6) form lamellipodia 
(indicated by white arrows) and establish front-to-rear polarity earlier in comparison to 
control cells (EV). Bar = 10 µm. B-C. The adjacent graphs show the percentage of spread 
cells and lamellipodia formation per spread cell in C7-6 and EV. Experiment performed in 
triplicate and is represented as the ± SEM. *p<0.005. D. C7-6 3D mono-cultured spheroids 
show increased structural organisation compared to EV cells. PAR3 expression at the plasma 
membrane is reduced in EV spheroids compared to C7-6 spheroids. Bar = 10 µm E. Western 
blot analysis from lysates extracted from C7-6 spheroids show increased Ln332, PAR3, 
ITAG6 and ELMO2 protein expression compared to EV spheroids. Adjacent western blot 
quantification graph gives the percentage average relative density for the proteins shown, 
(n=3, mean ± s.d). F. Type VII collagen overexpressing fibroblasts (C7) impart increased 
structural organisation when co-cultured with SCCRDEB3 keratinocytes compared to EV 
fibroblast. 3D culture, H&E and DAPI images show the difference in structural organisation 
between C7 and EV cells. E-cadherin (green) and β-catenin (red) show reduced plasma 
membrane localisation and expression in EV cells compared to C7 cells. The adjacent bar 
graphs show image quantification comparing fluorescence levels for b-catenin and e-cadherin 
in EV and C7 co-culture spheroids. G. western blot showing e-cadherin and beta-catenin 
protein expression in RDEBSCC3 co-culture spheroids shown in Fig 8F. Bar = 10 µm. 
 
 
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
